|Authors||Posther KE, Wilke LG, Giuliano AE|
|Journal||Semin. Oncol. Volume: 31 Issue: 3 Pages: 426-36|
|Publish Date||2004 Jun|
The current national sentinel lymph node (SLN) clinical trials for breast carcinoma address the prognostic and therapeutic utility of SLN dissection (SLND) in women with early-stage, clinically node-negative breast cancer. Following completion of these studies, overall survival, disease-free survival, morbidity, and quality of life of patients will be compared. Surgeon participation is crucial to the ongoing success of clinical trials in the field of breast cancer surgery.